EP4192378A1 - Tröpfchenweise digital gesteuertes aufbringen einer kryogenen flüssigkeit - Google Patents
Tröpfchenweise digital gesteuertes aufbringen einer kryogenen flüssigkeitInfo
- Publication number
- EP4192378A1 EP4192378A1 EP21773742.8A EP21773742A EP4192378A1 EP 4192378 A1 EP4192378 A1 EP 4192378A1 EP 21773742 A EP21773742 A EP 21773742A EP 4192378 A1 EP4192378 A1 EP 4192378A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- cryogenic liquid
- temperature
- application
- use according
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 254
- 239000000758 substrate Substances 0.000 claims abstract description 12
- 238000009826 distribution Methods 0.000 claims description 60
- 210000004027 cell Anatomy 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 34
- 210000001519 tissue Anatomy 0.000 claims description 29
- 210000000056 organ Anatomy 0.000 claims description 28
- 238000000338 in vitro Methods 0.000 claims description 22
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 230000001681 protective effect Effects 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 13
- 230000012010 growth Effects 0.000 claims description 12
- 238000001514 detection method Methods 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 9
- 230000001419 dependent effect Effects 0.000 claims description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 239000012620 biological material Substances 0.000 claims description 7
- 238000004113 cell culture Methods 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 238000012790 confirmation Methods 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 238000001727 in vivo Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 229910052786 argon Inorganic materials 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 239000001307 helium Substances 0.000 claims description 4
- 229910052734 helium Inorganic materials 0.000 claims description 4
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 4
- 238000005289 physical deposition Methods 0.000 claims description 4
- 231100000241 scar Toxicity 0.000 claims description 4
- 208000001126 Keratosis Diseases 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 210000002569 neuron Anatomy 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 206010000591 Acrochordon Diseases 0.000 claims description 2
- 208000002260 Keloid Diseases 0.000 claims description 2
- 206010023330 Keloid scar Diseases 0.000 claims description 2
- 206010039796 Seborrhoeic keratosis Diseases 0.000 claims description 2
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 2
- 206010064127 Solar lentigo Diseases 0.000 claims description 2
- 230000036760 body temperature Effects 0.000 claims description 2
- 229910052732 germanium Inorganic materials 0.000 claims description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 claims description 2
- 201000011066 hemangioma Diseases 0.000 claims description 2
- 210000001117 keloid Anatomy 0.000 claims description 2
- 230000003902 lesion Effects 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 208000008588 molluscum contagiosum Diseases 0.000 claims description 2
- 238000010422 painting Methods 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 201000003385 seborrheic keratosis Diseases 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 201000000849 skin cancer Diseases 0.000 claims description 2
- 201000000195 skin tag Diseases 0.000 claims description 2
- 241000237852 Mollusca Species 0.000 claims 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 230000000875 corresponding effect Effects 0.000 description 56
- 238000001816 cooling Methods 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 23
- 230000008901 benefit Effects 0.000 description 21
- 238000007639 printing Methods 0.000 description 19
- 230000001276 controlling effect Effects 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 13
- 238000001311 chemical methods and process Methods 0.000 description 13
- 230000008569 process Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 230000001105 regulatory effect Effects 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 9
- 239000007789 gas Substances 0.000 description 7
- 210000005036 nerve Anatomy 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000000151 deposition Methods 0.000 description 6
- 230000008021 deposition Effects 0.000 description 6
- 230000010261 cell growth Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000012937 correction Methods 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 230000007704 transition Effects 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000030833 cell death Effects 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 239000003570 air Substances 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000009529 body temperature measurement Methods 0.000 description 3
- 210000004207 dermis Anatomy 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000011477 surgical intervention Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000007792 gaseous phase Substances 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 231100000444 skin lesion Toxicity 0.000 description 2
- 206010040882 skin lesion Diseases 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 210000004003 subcutaneous fat Anatomy 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 241000272165 Charadriidae Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027457 Metastases to liver Diseases 0.000 description 1
- 208000004983 Phantom Limb Diseases 0.000 description 1
- 206010056238 Phantom pain Diseases 0.000 description 1
- 208000006787 Port-Wine Stain Diseases 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 210000003321 cartilage cell Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000000203 droplet dispensing Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000004556 laser interferometry Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 230000017095 negative regulation of cell growth Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 208000023958 prostate neoplasm Diseases 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
- A61B18/0218—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques with open-end cryogenic probe, e.g. for spraying fluid directly on tissue or via a tissue-contacting porous tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00982—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body combined with or comprising means for visual or photographic inspections inside the body, e.g. endoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0052—Body part for treatment of skin or hair
Definitions
- the invention relates to a use of a cryogenic liquid, a device which is designed for a corresponding use of a cryogenic liquid, and a system for producing a component, which includes a corresponding device.
- the invention relates to the use of a cryogenic liquid, characterized in that the cryogenic liquid is applied to a surface drop by drop in a digitally controlled manner in order to influence, in particular to specifically influence, a temperature of the surface.
- the use also includes, for example, influencing, in particular targeted influencing, of a temperature of an area lying beneath the surface, in particular of a layer or a substrate.
- Embodiments can have the advantage that they enable a targeted local thermo-kinetic influencing of the surface to which the cryogenic liquid is applied dropwise in a digitally controlled manner.
- the application of the cryogenic liquid droplets can serve to specifically, for example exclusively, specifically influence the temperature of the surface acted upon, for example a surface of a substrate.
- a temperature of the surface can be set by means of this targeted temperature influencing.
- a two-dimensional spatial temperature gradient can be generated in a targeted manner.
- the application can serve, for example, to selectively influence the temperature of an area below the applied surface, i.e. a three-dimensional area of an object whose surface is exposed to the cryogenic liquid.
- a temperature of the area can be set by means of this targeted temperature influencing.
- a three-dimensional spatial temperature gradient can be generated in a targeted manner.
- Application or “acting on” is understood here to mean such a dropwise, digitally controlled application of the cryogenic liquid that the applied droplets of the cryogenic liquid influence the temperature of the “acted on” surface.
- cryogenic liquid reaches the surface, remains on it or changes to a gaseous state of aggregation during or immediately after the application process and leaves the surface again.
- the “application” or “acting on” can include an application of the droplets, in which the applied droplets of the cryogenic liquid change into the gaseous state of aggregation during the application process.
- the cryogenic liquid does not reach the "acted on” surface.
- the transition to the gaseous state of aggregation creates, for example, a temperature sink over the "acted on” surface, which extracts heat from the "acted on” surface Heat is withdrawn, for example, via the atmosphere the surface is in.
- the temperature of the surface can be indirectly influenced by the cryogenic liquid.
- Whether the droplets reach the surface or not can be done, for example, by controlling or regulating one or more of the following parameters: droplet size, exit velocity, distance of the printhead from the surface, angle of droplet emission relative to the surface, ambient pressure and/or ambient temperature.
- cryogenic liquid can be specifically controlled, for example, whether, when and/or where the droplets reach the surface. This corresponds to focusing the cooling using the cryogenic liquid.
- the cryogenic liquid reaches the surface, locally stronger cooling of the surface and/or cooling that extends deeper into the area below the surface can be achieved. If the cryogenic liquid does not reach the surface, a weaker cooling of the surface locally and/or a cooling that extends less deeply into the area below the surface can be achieved.
- excessive stress on the surface due to direct contact of the surface with the cryogenic liquid can be avoided.
- undesired, for example chemical interactions of the cryogenic liquid with the surface and/or with substances applied to the cooled surface can be avoided.
- the temperature of the surface is recorded with a suitable, preferably non-contact, temperature measuring device during the application of the cryogenic liquid.
- a suitable, preferably non-contact, temperature measuring device for example, an infrared thermometer can be used.
- the temperature can be measured once or preferably several times, in particular continuously, during dpr Rpaii chlaPiin? ppmpwpn wprdpn 7 R 11m fp ⁇ ;t7iistpllpn. oh dip Tpmnpratur in
- a distribution scheme for distributing the cryogenic liquid on and/or over the surface can define, for example, where, when, how much cryogenic liquid is to be applied and whether the applied cryogenic liquid is to reach the surface or not.
- the distribution scheme defines a spatial and/or temporal distribution of the cryogenic liquid.
- the distribution scheme defines a spatially and/or temporally varying release quantity of the cryogenic liquid.
- the distribution scheme may define a distribution in which the delivery of the cryogenic liquid is modulated such that the cryogenic liquid reaches the surface at one or more locations while not reaching the surface at one or more other locations.
- a distribution can be implemented which includes both a direct and an indirect temperature influence on the surface in a locally controlled manner.
- thermo-kinetic influencing of the surface can be used, for example, to prepare the exposed surface, i.e. to set the temperature, for a subsequent processing operation on the surface.
- the thermo-kinetic influencing of the surface can serve to functionally influence the surface acted upon.
- the temperature setting can affect the physical, chemical and/or biological properties of the surface.
- the thermo-kinetic influencing of the surface can serve to structurally influence the surface that is acted upon.
- Embodiments can have the advantage that a cryogenic liquid is applied to the surface precisely drop by drop, ie drop by drop.
- the droplets can be small droplets.
- it can be a droplet size of less than 100 picoliters (pl), preferably less than 10 pl.
- they can be droplets with a droplet size of 1 pl to 10 pl, preferably 1 pl to 5 pl.
- a corresponding finely structured temperature control or temperature regulation on the surface makes it possible to control physical and/or chemical processes or reactions on the surface precisely or with pinpoint accuracy.
- the corresponding cooling effect can be controlled not only two-dimensionally but also three-dimensionally. and chemical nature of the surface. If more cryogenic liquid is applied locally, its cooling effect can last longer, for example, since a larger cold reservoir is provided.
- the temperature profile over time on the surface and in the interior of the object to which the action is applied, for example a substrate can be controlled or regulated in conjunction with a suitable temperature measurement. Based on the temperature measurement, for example, the amount of cryogenic liquid dispensed, such as the number and/or frequency of the droplets, can be regulated. For example, the delivery of the cryogenic liquid can be regulated to reach and/or maintain a predefined temperature.
- non-contact temperature measurement Preferably non-contact temperature measurement.
- a print head used for the application may be in contact with the surface or spaced from it.
- the digitally controlled deposition of the cryogenic liquid controls a location of the deposition in 2D or 3D, a volume of the deposition, and/or an angle of the deposition relative to the surface.
- the volume and/or the angle can be position-dependent.
- Embodiments can have the advantage that the application of the cryogenic liquid can be controlled as a function of position.
- the position of one or more print heads and/or one or more print nozzles of a print head can be detected and controlled relative to the surface.
- the dropwise deposition is dependent on a position in 2D, ie dependent on a position within a plane parallel to the surface.
- the dropletwise application occurs as a function of a 3D position, ie as a function of a position in three dimensions above the surface.
- the surface can include structures and the print head can be moved in the z direction perpendicular to the surface in addition to movements in the x and y directions parallel to the surface.
- the x, y and z directions are, for example, coordinates of a Cartesian coordinate system. particularly into the object having the surface.
- the volume of cryogenic liquid applied can be controlled, for example, by controlling the number and/or size of cryogenic liquid droplets applied at the same location.
- Angular control of the dropwise application of the cryogenic liquid relative ZL of the surface makes it possible, for example in the case of a structured surface, to cover corresponding structural elements of the surface with cryogenic liquid with pinpoint accuracy.
- side walls of the corresponding elevations and/or indentations in the surface can also be covered with cryogenic liquid in precise droplets.
- a digital controller is understood to mean a computer-based controller using control commands which, for example, controls the application of the cryogenic liquid in droplets as a function of the position.
- the dispensing position of the cryogenic liquid in 2D or 3D as well as the volume, i.e. the number of droplets and/or droplet size, and the angle of the droplet dispensing can be controlled.
- a rate at which the droplets are dispensed can also be controlled.
- Digital control of the drop-by-drop delivery of the cryogenic liquid can have the advantage that the amount of cryogenic liquid delivered can be precisely controlled, on a drop-by-drop basis, i.e., in the picoliter range for example.
- control is accomplished using digital control commands.
- Corresponding control commands translate, for example, a predefined distribution scheme for distributing the cryogenic liquid on and/or over the surface into instructions for controlling a pressure unit applying the cryogenic liquid to the surface.
- the cryogenic liquid is stored in a container that is fluidly connected to a digital printhead.
- the digital print head is digitally controlled to apply the cryogenic liquid drop by drop to the surface.
- the distribution scheme may define a distribution in which the delivery of the cryogenic liquid is modulated such that the cryogenic liquid reaches the surface at one or more locations while not reaching the surface at one or more other locations.
- a distribution can be implemented which includes both a direct and an indirect temperature influence on the surface in a locally controlled manner.
- Embodiments can have the advantage that, for example, a printing unit can be provided with a digital print head, which is digitally controlled and, depending on the control, dispenses the cryogenic liquid dropwise over the surface and/or applies it to the surface.
- the digital printhead is moveable relative to the surface.
- Embodiments can have the advantage that, by moving the digital print head in 2D or 3D, different dispensing positions can be assumed relative to the surface and the cryogenic liquid can be dispensed or applied to the surface depending on the respective dispensing position.
- an object comprising the surface can be movable in 2D and/or 3D relative to the print head.
- both the print head and the object can be movable.
- a detection unit is also provided, which detects the relative position of the surface and the digital print head to one another.
- the object and/or the digital print head can have position markings, which are detected by the corresponding detection unit.
- the corresponding acquisition unit can, for example, comprise an image sensor for acquiring image data.
- the corresponding detection unit can be configured for a distance measurement using interferometry, in particular laser interferometry.
- the position of the digital print head can be controlled so that it maintains a predefined minimum distance from the surface.
- the position of the digital printhead can be controlled to maintain a constant distance from the surface and/or a distance within a predefined interval.
- Rpj nipkwp p can dip position dps dieitalpn Driickkonfs so ppstpuprt wprdpn that dr
- the surface has a temperature above -50°C, above -20°C, in particular above 0°C, before the liquid is applied.
- the surface is at room temperature before the liquid is applied.
- the surface has the body temperature of an animal or a human before the liquid is applied.
- the surface has a maximum temperature of 100° C. before the liquid is applied.
- Embodiments can have the advantage that strong local cooling of the surface can be achieved by means of the cryogenic liquid.
- the temperature of the cryogenic liquid can be -275 to -75°C.
- the cryogenic liquid may be -272°C to -269°C in the case of helium, -259°C to 252°C in the case of hydrogen, -210 to -196°C in the case of nitrogen, 189 to 189°C in the case of argon -186°C, in the case of oxygen -218°C to -183°C and in the case of carbon dioxide -78.5°C.
- the corresponding temperature ranges can be varied by adjusting the pressure. For example, at a lower pressure, lower temperatures can be achieved with the cryogenic liquid without a liquid-to-solid phase transition. For example, at higher pressure, higher temperatures can be achieved with the cryogenic liquid without a liquid to gas phase transition.
- the cryogenic liquid is applied under a protective atmosphere.
- the cryogenic liquid is applied under a protective atmosphere with an increased or reduced oxygen content relative to the normal atmosphere.
- a protective atmosphere serves to prevent chemical reactions between the surface exposed to the cryogenic liquid and the atmosphere, i.e. the protective atmosphere.
- Embodiments can have the advantage that undesired chemical reactions of the cryogenic liquid and/or chemical components of the surface can be suppressed by using a protective atmosphere.
- protective gases such as nitrogen, carbon dioxide, oxygen, argon, helium, hydrogen and/or carbon monoxide can be used for the protective atmosphere.
- Gphalt dpr pnt ⁇ ;nrpchpndpn c.hiit7Pasp in dpr Atmo ⁇ ;nh rp can rplativ 7iir Normalat-
- an oxygen-free atmosphere can be used, such as in the case of using hydrogen as the cryogenic liquid.
- the oxygen content in the protective atmosphere can be increased relative to the normal atmosphere. This can be particularly advantageous if the cryogenic liquid is used in connection with an oxidation process. In this case, for example, no hydrogen is used as the cryogenic liquid.
- the cryogenic liquid is applied under overpressure. According to embodiments, the cryogenic liquid is applied under reduced pressure.
- Embodiments can have the advantage that by controlling the pressure under which the cryogenic liquid is applied, the temperature of the applied cryogenic liquid can be controlled. This means that the physical state of the cryogenic liquid in the liquid phase is dependent on the pressure. By changing the pressure, the temperature at which the cryogenic liquid is actually in the liquid state can be controlled. The temperature which the cryogenic liquid has when it is applied as a liquid can thus also be varied. For example, the pressure can be reduced and as a result lower temperatures can be achieved with the cryogenic liquid without it changing into the solid phase. For example, the pressure can be increased and as a result higher temperatures can be achieved with the cryogenic liquid without it changing into the gas phase.
- the pressure of the atmosphere in which the cryogenic liquid is applied to the surface it can be controlled whether the applied cryogenic liquid remains in the liquid phase or changes to a gaseous or solid phase.
- contact times between the cryogenic liquid and the surface can be controlled.
- this makes it possible to control the effect of the filling effect and, on the other hand, interactions of the cryogenic liquid with other physical and/or chemical processes for which the cooling takes place can be controlled and/or prevented.
- the pressure can be reduced, thereby achieving a transition of the cryogenic liquid from the liquid to the gaseous phase.
- the cryogenic liquid can be detached from the surface again within a short time and a disturbance of further subsequent physical and/or chemical processes can be avoided.
- Embodiments can have the advantage that a 2D and/or 3D structure of the surface or of the object comprising the surface is recorded.
- a corresponding detection can, for example, take place visually using a camera.
- the detection can take place using a microscope.
- a scanning probe microscope such as a scanning tunneling microscope, atomic force microscope, magnetic force microscope, scanning near-field optical microscope or a scanning near-field acoustic microscope can be used.
- a digital model for example a 3D model, of the surface is created using the recorded data. Based on the recorded 2D and/or 3D surface structures, structural elements of the surface to which the cryogenic liquid is to be applied can be determined.
- a corresponding determination of the structure elements can take place, for example, by a selection by a user or automatically using an image recognition method.
- the structural elements of the surface are determined and/or the control data are generated automatically.
- the control data is generated automatically as a function of the structural elements of the surface determined, for example, by means of an image recognition method.
- characteristic properties can be, for example, geometric properties or physical properties, such as color in the case of an image acquisition of the surface structure. Color here refers to the reflectance behavior when irradiated with light of one or more wavelengths in the visible and/or non-visible wavelength range, ie monochromatic or polychromatic light.
- control data can be generated which control the application of the cryogenic liquid to the specific structural elements.
- the corresponding control data can define, for example, at which positionpn WPICHP Vnlumpn krvoppnpr Flii ⁇ ; ⁇ ;ipkpit in wplcnpm Winkpl ar>7iipphpn h?w aiif7iihrin-
- the use also includes creating a digital distribution scheme for applying the cryogenic liquid to the specific structural elements depending on the detected 2D and/or 3D structure.
- the control data is configured to control the application of the cryogenic liquid to the particular structural elements according to the distribution scheme.
- a digital distribution scheme is created that defines the application of the cryogenic liquid to the specific structural elements depending on the detected 2D and/or 3D structure.
- a 3D model of the structures of the surface is used for this purpose, for example.
- a corresponding distribution scheme can be used in particular to visualize a proposal for applying the cryogenic liquid.
- a corresponding suggestion is generated automatically, for example, and/or using user input.
- the recorded 2D and/or 3D structure or a digital model of the surface generated using the recorded data can be used to define at which positions and at what angles cryogenic liquid is to be applied.
- it can be defined on the basis of 3D structures, for example, which volume of cryogenic liquid is to be applied.
- the control data is designed to control the application of the cryogenic liquid to the specific structural elements according to the distribution scheme.
- the control data can be a translation of the distribution scheme into control data, i.e. control commands, for a controller controlling the application of the cryogenic liquid.
- the digital distribution scheme is displayed on a display device and controlling the application of the cryogenic liquid using the control data according to the distribution scheme entails receiving confirmation of the displayed distribution scheme via an input device.
- Embodiments can have the advantage that the digital distribution scheme is displayed on the display device and is thus visualized for a user.
- the user can there"; pnt nrpchpndp Vprtpihinp ⁇ ; ⁇ ;chpma nrüfpn Rpj nipkwpi p will be there «; pnt nrpchpndp Vpr Change droplet size, number of droplets and/or droplet rate.
- angles can be set at which the cryogenic liquid is applied.
- use of the control data according to the distribution scheme requires explicit confirmation of the displayed distribution scheme by the user. A corresponding confirmation can be received from the user directly in response to the display of the distribution scheme or after receiving correction information and changing the distribution scheme according to the received correction data.
- the surface is living or dead biological material.
- the biological material includes in particular: microorganisms, a cell culture and/or a cell assembly, in particular an in-vivo or in-vitro cell assembly, in particular an in-vitro cell assembly for the growth of an artificial organ or part of an organ, the biological material being human or animal skin or tissue sample.
- Embodiments may have the advantage of having a cooling rate ("freezing rate") of over 100°C per minute while cooling the tissue to below -25°C, preferably to a temperature of -45°C to -25°C It has been shown that a very high proportion of the cells cooled in this way die as a result.This temperature range is particularly useful in those applications in which the low temperatures are used for the targeted killing of cells in a spatially narrowly defined area.
- the amount of cryogenic liquid applied is metered to cool the temperature of the cells to about 0.5°C to 15°C. This leads to a local suppression of pain sensations and can, for example, be carried out in addition to local surgical, e.g. laser-based interventions. For example, initially on a specific tissue to be operated on or treated with a laser with the
- a control device can control the amount of cryogenic liquid delivered via the printhead per unit of time and/or the position of the printhead relative to the surface in such a way that the amount and frequency of the applied droplets ensures that the temperature of the tissue surface and/or the cells within an in vivo or in vitro tissue is maintained within a predefined temperature range for a predefined period of time.
- the temperature range and the depth profile of the temperature range depend on the respective application (cryogenic destruction of cells or pain reduction, depth and 3D structure of subcutaneous structures (e.g. warts, cancerous growths, etc.).
- the method is repeatedly applied to the same surface multiple times, e.g., twice or three times, e.g., multiple times within an hour or multiple times within a second. This can further increase the proportion of dead and/or thermally inactivated cells.
- the controller is configured to control the application of droplets of the cryogenic liquid to the surface such that the application is continuous and maintains discrete areas on and below the surface at a defined temperature for a defined period of time.
- the device has multiple containers for multiple volumes of cryogenic liquid.
- the printhead has a plurality of nozzles, each fluidly connected to one of the reservoirs.
- the containers contain different cryogenic liquids and/or cryogenic liquids of different temperatures. This makes it possible, similar to inkjet printing, to cool down very finely granular surface areas and/or tissue areas to a specific temperature by complex control of the print pattern generated by the individual printing nozzles.
- the printing process can be controlled in such a way that a first cryogenic liquid from a first container with a particularly low temperature is applied in high droplet density by a first nozzle onto a first area of the surface, under which the 7pntrum dps 711 yprstörpndpn GPWPHPS (7th R War7P Krphsppswear ptc ) hp- Drop-densely applied to surrounding, "second" areas of the surface. The surrounding skin and tissue areas are cooled, but at temperatures above 0°C, to avoid ice formation.
- the device has a plurality of nozzles which can be controlled individually and emit droplets of the cryogenic liquid of different sizes and/or different frequencies. This also makes it possible to cool down very finely granular surface areas and/or tissue areas to a specific temperature by complex control of the print pattern generated by the individual print nozzles.
- the printing process can be controlled in such a way that a first nozzle applies the cryogenic liquid in a high droplet density and/or with a large droplet volume to a first area of the surface, below which the center of the tissue to be destroyed is located.
- the tissue is cooled to such an extent that the cells die as a result of the cell walls being perforated by ice crystals.
- a second nozzle applies the cryogenic liquid in a low droplet density and/or with a small droplet volume to surrounding, "second" areas of the surface.
- the surrounding skin and tissue areas are cooled here, but to temperatures above 0°C to avoid ice formation .
- “Small” or “large/high” drop density or volumes can be a relative specification, which means, for example, that a "small” drop has a volume that is at least 20% smaller than a "large” drop or that a "small “ Drop density is at least 20% less than a "large” drop density.
- cryo-based destruction of tissue and a cryo-based, non-destructive cooling of surrounding tissue for the purpose of reducing pain can be carried out in a single application step.
- low temperatures are already being used to relieve pain during surgical interventions (e.g. with scalpels or lasers).
- these methods have the disadvantage that they are associated with a high outlay in terms of equipment (additional cryogenic devices are required in addition to the surgical devices).
- embodiments of the invention can have the advantage that the surgical intervention and the cooling for pain relief can be carried out in a single work step and with the same device.
- cryogenic liquid is used here to refer to a liquid that is used to cool objects by applying this liquid, e.g. in technical applications or scientific experiments.
- a cryogenic liquid has a temperature below 0 °C.
- the cryogenic liquid be a liquid gas that is generated, for example, by central facilities or commercial providers by liquefying the corresponding gases (for air/nitrogen, for example, using the Linde process) and brought to the respective application in special transport containers be, for example, liquid nitrogen and/or liquid helium, hydrogen, nitrogen, argon, oxygen or mixtures of two or more of the aforementioned gases.
- the cryogenic liquid used for biological, medical and/or cosmetic purposes can in particular be liquid nitrogen or other non-toxic, biocompatible cryogenic liquids.
- cryogenic liquids makes it possible to achieve very high freezing speeds and is less dangerous to handle (risk of explosion and fire) than liquid oxygen, for example.
- the print head is designed as a matrix print head in which an application pattern or print image is generated by the targeted firing or deflection of small liquid droplets.
- the printhead may be a drop-on-demand printhead, i.e., a printhead that fires a single drop.
- the printhead is configured to generate droplets having a droplet size of less than 100 picoliters (pl), preferably less than 10 picoliters.
- the production of such fine droplets can have the advantage that a particularly finely structured pattern can be produced.
- Top devices are in the range of 1 pl to 5 pl.
- the droplets can be sprayed at a frequency of more than 10,000 drops/second.
- the print head contains a plurality of print nozzles that can emit the droplets at a nozzle-specific frequency, with the nozzles being able to be controlled individually and droplets being able to be generated at different frequencies.
- the generation of very small droplets in high and preferably variabe adjustable - Scar tissue, especially excessive scar tissue (keloid);
- the removal of pigment spots, scar tissue, port-wine stains, warts and/or keratoses can serve aesthetic purposes.
- the use is:
- cryosurgical procedure in particular a local dermatological procedure
- an interventional therapy method for tumors e.g. therapy for liver metastases, lung or prostate tumors;
- a procedure for the temporary or permanent inactivation or destruction of nerve cells e.g. pain therapy for phantom pain or to reduce pain caused by surgical interventions.
- the temporary inactivation of nerve cells to reduce surgery-related pain can be carried out before, during or after the operation.
- the operation is a cryosurgical procedure performed by the same device that performs the cryogenic liquid for pain relief.
- the cryosurgical intervention and the pain treatment intervention are controlled and performed together in a single work step.
- a cryogenic jet of at least 5 milliseconds with liquid nitrogen can already bring about significant pain relief.
- the surface is human or animal skin in vivo or in vitro.
- An "in vitro" skin is a two-dimensional or three-dimensional cell structure that consists of or contains skin cells and is cultivated using various methods on nutrient media or nutrient substrates.
- "in vitro" tissues such as in vitro organs are involved or organ parts to those cultured outside of a human or animal organism in an artificial environment.
- this enables very fine-grained local growth control.
- Growth-inhibiting active ingredients can hardly be applied locally because they diffuse in the medium.
- the cryogenic liquid can also be used to control the cell inhibition over time, as it can be ended or extended at any time.
- growth-inhibiting substances can no longer be removed from the cell culture medium.
- the pressure device can be completely integrated into a sterile incubator for cell cultures, so that it is not necessary to open the incubator to carry out manual steps manipulating cell growth.
- the cryogenic liquid is applied, for example, at least before one of the structuring steps in order to influence the subsequent structuring step.
- a structuring step takes place through the application of the cryogenic liquid.
- Embodiments can have the advantage that local structuring processes of a substrate can be controlled through the use of the cryogenic liquid.
- the surface temperature can be varied locally with pinpoint accuracy by applying the cryogenic liquid.
- Physical and/or chemical processes affecting the surface can depend on the corresponding surface temperature.
- chemical reaction rates can be controlled.
- a deposition rate can be temperature-dependent and structure formation on the surface can thus be controlled.
- a chemical removal process such as an etching process, can be temperature dependent and thus the rate of removal can be controlled by controlling the local temperature.
- a synthesis reaction in the course of a polymerization i.e. a synthesis reaction which converts identical or different monomers into polymers, can be temperature-dependent.
- a corresponding polymerization process can be locally controlled by a local temperature variation.
- the structuring step is a chemical reaction, a physical deposition step and/or a polymerization.
- a reaction speed of the chemical reaction is controlled locally by the application of the cryogenic liquid.
- the application of the cryogenic liquid locally changes an aggregate state of a substance involved in the chemical reaction, the physical deposition step and/or the polymerization.
- a local temperature variation can locally vary the states of aggregation.
- the substances involved can be converted from a gas phase into a liquid or solid phase by cooling.
- a corresponding change in the state of aggregation can influence a chemical reaction, a physical separation step iind/odpr pinp Pnlvmprisatinn hahpn Rpi ni kw i cannpn by pinpn Phaspn- Embodiments can have the advantage that the cryogenic liquid can be used, for example, for structuring a substrate on which a circuit is to be printed.
- the structuring can create a structural requirement that is necessary for the imprinting or the geometric configuration of the circuit.
- the cryogenic liquid is used to produce a component.
- the component is, for example, an electronic component.
- the electronic component is, for example, an integrated electronic circuit, for example based on silicon and/or germanium or on a polymer electronic basis.
- the component can be, for example, an electronic component, a mechanical component and/or a component that provides a specific surface structure.
- a surface structure can be used, for example, to support, prevent and/or control a mechanical, electromagnetic or chemical process.
- Mechanically the surface structure can, for example, support, prevent and/or control mechanical movements, for example of atoms, molecules or moving elements on the surface.
- Electromagnetically the surface structure can, for example, support, prevent and/or control electromagnetic interactions on the surface or across the surface.
- the surface structure can, for example, support, prevent and/or control a chemical process, for example as a catalyst or inhibitor.
- the cryogenic liquid is applied before a doping step in order to locally modulate a doping.
- Embodiments can have the advantage that doping can be locally modulated by local temperature control using the cryogenic liquid.
- doping can take place by means of diffusion.
- Diffusion is a thermally activated balancing process of a concentration difference, for example in a solid. If there is a concentration difference, foreign atoms can, at sufficiently high temperatures, pr pindrinppn and I hpwpppn Dip pntsnrpchpndp Rpwppun? dpr Frpmdatomp
- the invention relates to a device designed for carrying out the use of a cryogenic liquid according to one of the embodiments described here.
- the device is configured, for example, for one or more or each of the aforementioned embodiments of using the cryogenic liquid.
- the invention relates to a device for applying a cryogenic liquid to a surface to influence a temperature of the surface with a container for holding the cryogenic liquid, a digital print head which is fluidically connected to the container and a control device for controlling the print head for dropwise application of the cryogenic liquid to the surface.
- Embodiments can have the advantage that a corresponding device can be provided, for example in the form of a printing unit, which prints the cryogenic liquid drop by drop onto the surface using the digital print head.
- the dropwise application is controlled by a control device.
- the corresponding control device uses control data, for example.
- the corresponding control data can result, for example, from a distribution scheme provided for applying the cryogenic liquid.
- the control data can translate the corresponding distribution scheme into control commands, with which the control device controls the printing unit.
- the control device can be a device integrated into the printing unit or, for example, a computer system to which the printing unit is connected.
- the print head contains a plurality of individually controllable nozzles.
- Each of the nozzles is configured to control the size and/or frequency of droplets ejected from the respective nozzle in response to control data from the controller.
- the device is a medical device, in particular a medical device for the selective application of the cryogenic liquid to an organ or a part of an organ.
- the organ or organ part can be an in-vivo or in-vitro organ or organ part.
- the organ can in particular be human or animal skin.
- the medical device can also be pin Gpr t 711m splpktivpn Aufhrinppn dpr krvoppnpn getssipkpit on pinzplnp and is 0.05 millimeters thick.
- the horny layer on the palms of the hands and the soles of the feet is up to several millimeters thick ("cornea").
- the dermis consists mainly of connective tissue fibers and serves to nourish and anchor the epidermis. It contains blood vessels, nerves and the smooth muscles that are important for temperature regulation and blood vessels.
- the hypodermis contains the larger blood vessels and nerves for the upper skin layers as well as the subcutaneous fat and loose connective tissue.
- the subcutaneous tissue contains sensory cells for strong pressure stimuli, for example the lamellar bodies.
- all skin layers can be cooled to temperatures below 10°C, also below 0°C, also below -20°C, also below -40°C for a predefined period. This can destroy tissue and/or reduce the activity of the nerves located therein, in particular for the purpose of pain relief).
- the device can be embodied as a tool with a shape that enables the print head to be guided and positioned with one hand.
- the shape can in particular have the form of a pen, painting or drawing implement.
- the device may have an elongate shape and the print head mounted at the front end of the device.
- the device has a holding portion designed to allow the device to be picked up and guided by a human hand.
- the holding area can have a depression or taper and/or consist of elastic material.
- the device can be an endoscope.
- the device can comprise a first unit, which contains the container and the control device, and a second unit, which is intended for introduction into the body in order to destroy metastases or other undesirable tissue formations there and/or temporarily or permanently to individual nerves disable.
- the second unit contains the print head and optionally further elements (camera, temperature sensor, possibly surgical forceps, laser, etc.) and is coupled to the first unit via a preferably flexible connection.
- the device is a pressure device that is an integral part of a device for the automated cultivation of one or more cell cultures.
- the device is an apparatus designed to be movable in two or three dimensions for charging the individual cells and/or the organ or part of an organ, in particular an organ or part of an organ cultivated in vitro, with the cryogenic liquid.
- the apparatus includes a temperature sensor and is designed to detect the surface temperature of the organ or organ part during exposure to the temperature sensor and to use it to regulate exposure. For example, the number, size and/or exit velocity of the cryogenic droplets and/or the distance or angle of the print head relative to the surface can be adjusted such that the temperature of the surface is within a predefined temperature range. This very fine-grained control of the surface temperature can be particularly advantageous when biological material is exposed, since temperatures that are too low can lead to the destruction of individual cells or entire tissue.
- the death of cells should be avoided in application scenarios in which it is only a matter of locally slowing down cell growth or relieving pain. But also in applications in which specific tissue areas are to be destroyed, a narrow focus of the application area is advantageous since damage to the surrounding tissue can be prevented.
- the device may be configured to adjust the surface temperature to a range that slows cell growth but does not result in cell death.
- the device can be configured so that when the tissue or the organ or part of an organ is exposed to a cryogenic liquid, the surface temperature is within a target temperature, with the target temperature being selected such that tissue damage and cell death is avoided.
- the application process can be regulated in such a way that the cryogenic droplets are already in contact with dpr before they reach the surface of the cells or tissue 7PIIP prfolet «jondprn dip Kühhin?
- a device described here for applying a wide variety of biological and non-biological materials can also be equipped with a - preferably contactless - temperature sensor and/or can be configured to carry out the application in such a way that the temperature of the exposed surface is within a target temperature range , which excludes damage to the material.
- a temperature range can, for example, be a temperature range in which a cooling effect only takes place via the ambient air, because the droplets have evaporated before they reach the surface.
- the invention relates to a system for producing a component, in particular an electronic component, comprising a device according to one of the embodiments described above.
- the surface is a substrate.
- the system carries out one or more structuring steps in order to structure the surface and/or to apply a two-dimensional or three-dimensional structure to the surface.
- the cryogenic liquid is applied by the device, for example, at least before one of the structuring steps in order to influence the subsequent structuring step.
- a structuring step takes place through the application of the cryogenic liquid.
- the component can be, for example, an electronic component, a mechanical component and/or a component that provides a specific surface structure.
- Such a surface structure can be used, for example, to support, prevent and/or control a mechanical, electromagnetic or chemical process.
- the surface structure can, for example, support, prevent and/or control mechanical movements, for example of atoms, molecules or moving elements on the surface.
- Electromagnetically, the surface structure can, for example, support, prevent and/or control electromagnetic interactions on the surface or across the surface.
- the surface structure can, for example, support, prevent and/or control a chemical process, for example as a catalyst or inhibitor.
- Embodiments can have the advantage that the cryogenic liquid can be used in the course of manufacturing a component, such as an electronic component, for controlling physical and/or chemical processes.
- a system for producing a corresponding component includes a corresponding
- a pressure unit can be provided, for example, which prepares the surface accordingly by applying the cryogenic liquid. Structuring then takes place in an adjacent structuring unit, into which the treated surface is transferred.
- FIG. 1 is a schematic view of an exemplary apparatus for applying a cryogenic liquid
- FIG. 2 is a schematic view of an exemplary pressure unit for applying a cryogenic liquid
- FIG. 3 is a schematic view of an exemplary pressure unit for applying a cryogenic liquid
- FIG. 4 shows a schematic view of an exemplary system for producing a component
- FIG. 5 shows a flow chart of an exemplary method for applying a cryogenic liquid
- FIG. 6 shows a flow diagram of an exemplary method for applying a cryogenic liquid
- FIG. 7 shows a flow diagram of an exemplary method for applying a cryogenic liquid
- FIG. 8 shows a schematic view of an exemplary device for the cryosurgical application of a cryogenic liquid
- FIG. 9 shows a schematic view of an exemplary device for manual application of a cryogenic liquid in vitro.
- FIG. 10 shows a schematic view of an exemplary device for the automatic application of a cryogenic liquid in vitro.
- FIG. 1 shows an exemplary device 100 for applying a cryogenic liquid 103 dropwise to a surface 112 of an object 113.
- pinp pushbutton 104 hprpitpp tpllt WPICHP pinpn pushbutton 106 is included. wplchpr about that cryogenic liquid 103 to be applied is located.
- one or more print heads 106 can be provided, which can be moved in two or three spatial directions by a movement unit 107 .
- the print heads 106 can, for example, each comprise one or more individually controllable nozzles.
- each of the nozzles may be configured to control the size and/or frequency of droplets ejected from the respective nozzle in response to commands from a controller 102 .
- a protective atmosphere can prevail inside the printing unit 104, for example.
- the pressure in the printing unit 104 can be increased or decreased compared to the normal pressure of the environment.
- the control device 102 can be a computer system or a computer device, for example.
- the corresponding computer device can include hardware 114 with one or more processors and a memory in which program instructions are stored for controlling the computer system 102 and the printing unit 104.
- the control device 102 can input devices, such as a keyboard 116 and/or a mouse 118.
- the control device can comprise a display device 120, such as a screen, on which a graphical user interface or GUI ("Graphical User Interface") is displayed.
- the corresponding graphical user interface 122 can, for example, display an image 127 of the surface 112 as well as a distribution scheme 126 which displays an intended distribution of the cryogenic liquid on and/or over the surface 112 .
- the graphical user interface 122 may include controls 124 to confirm a proposed distribution scheme 126 and/or to correct the corresponding proposal.
- a user can confirm the proposed distribution scheme 126 and/or make corrections to the proposed distribution scheme 126 by means of the corresponding control elements 124 using the input devices 116 , 118 .
- the device 100 may further include a capture device.
- the corresponding detection device can be, for example, a visual detection device such as a camera. In particular, the detection device can be a microscope. Structure elements to which the cryogenic liquid 103 is to be applied can be determined on the basis of the image 127 of the surface 112 .
- FIG. 2 shows a detailed view of an exemplary printing unit 104 from FIG. 1.
- the corresponding printing unit 104 includes a print head 106.
- the corresponding print head can include one or more printing nozzles.
- a position of the corresponding print head relative to the surface 112 can be controlled by a movement unit 107, for example.
- the corresponding movement unit 107 makes it possible, for example, to move the print head 106 relative to the surface 112 in 2D, ie in a plane parallel to the surface 112, and/or in 3D.
- a distance D of the print head 106 from the surface 112 can be set.
- the corresponding distance D can be varied, in particular depending on a 2D position relative to the surface 112.
- the distance D can be kept constant and/or kept constant within a predetermined interval.
- a minimum distance between the print head 106 and the surface 112 can be maintained, for example, by regulating the distance D.
- an angle a can be varied, at which the print head 106 applies the cryogenic liquid to the surface 112 drop by drop.
- a corresponding variation of the angle a can take place, for example, by pivoting the print head 106 about one, two or three pivot axes which are perpendicular to one another.
- a protective atmosphere can be generated within the pressure unit 104 and/or the prevailing pressure can be regulated.
- a protective atmosphere and/or regulating the pressure under which the cryogenic liquid is applied to the surface 112 the effect of the cryogenic liquid, in particular the effect on the surface and/or on substances involved in physical and/or chemical reactions, can be targeted be controlled locally.
- the effect of the substances involved in the physical and/or chemical reactions can be controlled by using a protective atmosphere and/or by regulating the pressure.
- FIG. 3 shows a further exemplary embodiment of a printing unit 104 which comprises a plurality of print heads 106.
- the movement unit 107 can be designed, for example, so that the individual print heads 106 can be moved independently of one another in 2D and/or 3D.
- the corresponding print heads can, for example, be pivoted independently of one another about one, two and/or three pivot axes which are perpendicular to one another.
- Fiei ir 4 7Pi?t pi np An lapp 1 0 7 iir Hp r tp llu np pi np ⁇ ; Ra i ip lp mpnt"; i n ⁇ ;hp ⁇ ;nnnp rp pi np ⁇ ; p lp kt
- the application of the cryogenic liquid can, for example, take place simultaneously with a structuring of the surface 112 .
- the printing unit 104 would be integrated into the structuring unit 109 .
- the cryogenic liquid can be applied before a corresponding structuring step, as shown in FIG.
- the cryogenic liquid is applied to the surface 112 of the object 113 by means of the print head 106 that can be positioned using the movement unit 107 .
- the application can take place, for example, according to a previously defined distribution scheme.
- the corresponding object 113 is then transferred to the structuring unit 109 .
- the same atmospheres prevail in the printing unit 104 of the structuring unit 109, in particular a protective atmosphere.
- the pressure in both units 104, 109 can be identical. Alternatively, the pressures prevailing in the units 104, 109 could differ.
- the structuring unit 109 can be, for example, a unit that is configured to carry out a chemical reaction, a physical deposition step and/or a polymerization.
- the structuring unit 109 provides, for example, the substances involved in the corresponding structuring step and controls the physical framework conditions.
- a local temperature variation for influencing the structuring step then occurs, for example, through the local distribution of the cryogenic liquid.
- FIG. 5 shows a flow chart of an exemplary method for applying a cryogenic liquid to a surface.
- a distribution scheme is created.
- a corresponding distribution scheme can be specified or set by a user, for example.
- a distribution scheme can be based on a predefined structure to be produced of the surface to which the cryogenic liquid is to be applied.
- a corresponding structuring template is provided, which defines the predefined structure to be produced.
- the distribution scheme can be a distribution of the cryogenic liquid according to the predetermined structural shapes.
- the distribution scheme for distributing the cryogenic liquid on and/or over the surface can define, for example, where, when, how much cryogenic liquid is to be applied and whether the applied cryogenic liquid is to reach the surface or not.
- the distribution scheme defines a spatial and/or temporal distribution of the cryogenic liquid.
- Example- wpi p dpfiniprt da «; prtpiliinp ⁇ ; ⁇ ;chpma pinp räiimlichp iind/ndpr 7Pilichp variiprpndp Ahea- includes both a direct and an indirect temperature influence on the surface.
- control data is generated using the distribution scheme.
- the corresponding control data are, for example, control commands for controlling one or more print heads for applying the cryogenic liquid to a surface.
- the control data can define at which positions of the printhead relative to the surface, how much cryogenic liquid is to be applied and at what angle.
- an appropriate device such as a pressure unit, is controlled to apply the cryogenic liquid to the surface using the control data.
- the cryogenic liquid is dispensed over the surface and/or the cryogenic liquid is applied to the surface according to the distribution scheme generated in block 204 .
- further physical and/or chemical processes can be carried out in a controlled manner, which are influenced by the local temperature change caused by the cryogenic liquid.
- FIG. 6 shows a flow chart of an exemplary method for applying a cryogenic liquid which, in addition to the method shown in FIG. 5, includes detecting a structure of the surface in block 200.
- a corresponding detection of a structure of the surface can be advantageous, for example, if the physical and/or chemical processes which are to be influenced by the application of the cryogenic liquid depend on predetermined structures of the surface.
- the structure of the surface is recorded in block 200, for example.
- structural elements are determined to which the cryogenic liquid is to be applied. The corresponding determination of the structure elements can take place, for example, by input from a user and/or can take place automatically. In the case of an automatic determination of the structural elements, a method for image recognition can be used, for example.
- the corresponding structural elements can be determined, for example, based on their geometry and/or their visual appearance, such as their color.
- the distribution scheme in block 204 is generated, for example, based on the determined structural elements such that the positions at which the cryogenic liquids are applied to the surface correspond to the positions of the structural elements.
- nip meneen of the applied kvoeenen Fl i issiekeit in Ah- Controlling a corresponding device for applying the cryogenic liquid is used. Subsequent to or at the same time as the application of the cryogenic liquid, for example, further physical and/or chemical processes can be carried out in a controlled manner, which are influenced by the local temperature change caused by the cryogenic liquid.
- FIG. 7 shows a flow chart of a further exemplary method for applying a cryogenic liquid to a surface.
- the structure of a surface to which the cryogenic liquid is to be applied is first detected in block 200 .
- structural elements are determined which are to be at least partially covered with the cryogenic liquid.
- a distribution scheme for applying the cryogenic liquid is generated using the determined structural elements.
- the generated distribution scheme is displayed on a display device, for example.
- a user's confirmation of the distribution scheme is received.
- corrections to the distribution scheme can be received and the displayed distribution scheme corrected accordingly. For example, after the corrections have been completed, the correspondingly corrected distribution scheme is confirmed.
- control data for controlling a device for applying the cryogenic liquid according to the distribution scheme is generated.
- the corresponding device is controlled using the control data generated in block 210 .
- one or more further physical and/or chemical processes can take place in a controlled manner, which are controlled locally by the local temperature control using the cryogenic liquid.
- FIG. 8 shows an exemplary device 700 for applying a cryogenic liquid 708 to a surface 712 for use in a medical or cosmetic context.
- the device can be used to destroy or remove skin lesions.
- the apparatus includes a container 702 for holding the cryogenic liquid, a digital printhead 706 fluidly connected to the container, and a controller 704 for controlling the printhead to apply the cryogenic liquid dropwise to the surface.
- Rpi dpr device 700 can p ⁇ ; So I urn pin mpniyintpchnischps Gpraet inshpsondprp
- the surface 712 can be, for example, the epidermis of human or animal skin 710 or some other surface of individual cells or a cell assembly.
- the epidermis is a stratified squamous epithelium usually between 0.03 and 0.05 millimeters thick.
- the horny layer on the palms of the hands and the soles of the feet is up to several millimeters thick ("cornea").
- the dermis consists mainly of connective tissue fibers and serves to nourish and anchor the epidermis. It contains blood vessels, nerves and the smooth muscles that are important for temperature regulation and blood vessels.
- the hypodermis contains the larger blood vessels and nerves for the upper skin layers as well as the subcutaneous fat and loose connective tissue.
- the subcutaneous tissue contains sensory cells for strong pressure stimuli, for example the lamellar bodies.
- all skin layers can be cooled to temperatures below 10°C, also below 0°C, also below -20°C, also below -40°C for a predefined period.
- tissue can be destroyed and/or the activity of the nerves located therein can be reduced, in particular for the purpose of relieving pain before, during or after a local operation.
- the application of the cryogenic liquid is preferably not carried out according to the "all or nothing" principle, but via a large number of nozzles which can be controlled individually and eject the droplets of the cryogenic liquid in such a way that the droplet ejection of the various nozzles differs in terms of size and/or or frequency.
- This can result in complex patterns that adapt individually to the skin and subcutaneous structures to be treated. For example, it is even possible to produce ring-shaped pressure patterns with very strong cooling, so that the cells within the ring-shaped pressure pattern die but the cells in the center not. Such structures occur again and again in various skin lesions.
- cryogen applied to the skin creates a heat sink beneath the skin's surface, formed as a temperature gradient. The steeper the gradient, the faster a given amount of heat is extracted. Thus, to be successful, the cryogen should produce a large drop in surface temperature as quickly as possible.
- FIG. 9 shows a manually operable device 800 for applying the cryogenic liquid in vitro.
- flat 2D or 3D cell structures such as bacterial cell structures (“biofilm”), artificial skin, artificial cartilage, associations of liver cells, muscle cells, etc.
- biofilm bacterial cell structures
- the growth of the cells can be controlled.
- the print head 706 is positioned manually on the areas of the cell assembly that are to be destroyed or slowed down in growth.
- a highly localized application of a cryogenic liquid can be used not only for medical and cosmetic purposes but also for scientific questions, for example to promote metabolism and cell growth in certain areas amen or the cell metabolism selectively in a selected region by very rapid cooling to below 0°C for further analysis.
- FIG. 10 shows a device 900 for the automatic application of the cryogenic liquid via a print head 706 in vitro.
- the device 900 is attached to a movable element 902 in a rigid or movable (eg rotatable and/or pivotable) manner.
- a movable element 902 eg rotatable and/or pivotable
- the automatic drip application of cryogenic liquid via printhead 706 may have the advantage of increasing control over exactly where cryogenic liquid is applied.
- Corresponding embodiments are therefore particularly suitable for high-precision applications.
- the print head 706 preferably has a plurality of individually controllable print nozzles.
- the device and the arm 902 are an integral part of an incubator or other device that is used to control the temperature and optionally also to move one or more prokaryotic or eukaryotic cell cultures.
- This can have the advantage that the device can be regularly positioned on certain surface areas of the cell assembly in order to apply the cryogenic liquid there and to control cell growth. Since both the device 900 and the movable unit 902 are part of the incubator or device, a cryotreatment can be carried out repeatedly without increasing the risk of infection.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102020123415.5A DE102020123415B4 (de) | 2020-09-08 | 2020-09-08 | Tröpfchenweise digital gesteuertes Aufbringen einer kryogenen Flüssigkeit |
PCT/EP2021/074628 WO2022053471A1 (de) | 2020-09-08 | 2021-09-08 | Tröpfchenweise digital gesteuertes aufbringen einer kryogenen flüssigkeit |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4192378A1 true EP4192378A1 (de) | 2023-06-14 |
Family
ID=77897611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21773742.8A Pending EP4192378A1 (de) | 2020-09-08 | 2021-09-08 | Tröpfchenweise digital gesteuertes aufbringen einer kryogenen flüssigkeit |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4192378A1 (zh) |
CN (1) | CN116601420A (zh) |
DE (1) | DE102020123415B4 (zh) |
WO (1) | WO2022053471A1 (zh) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3263275B2 (ja) | 1994-04-05 | 2002-03-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 生体組織のレーザー処理のための装置並びに火焔状斑点母斑のレーザー処理装置 |
US6226996B1 (en) * | 1999-10-06 | 2001-05-08 | Paul J. Weber | Device for controlled cooling of a surface |
WO2003101736A2 (en) | 2002-05-29 | 2003-12-11 | Arizona Board Of Regents, Acting On Behalf Of Arizona State University | Nanoscale ink-jet printing |
US20100087806A1 (en) * | 2008-10-07 | 2010-04-08 | Vandolay, Inc. | Automated Cryogenic Skin Treatment |
US9022999B2 (en) | 2012-05-02 | 2015-05-05 | Elwha, Llc | Fluid spraying apparatuses, and related systems and methods |
EP3520728A1 (en) * | 2018-02-05 | 2019-08-07 | Fotona d.o.o. | Micro-pulsed liquid spray for cooling |
-
2020
- 2020-09-08 DE DE102020123415.5A patent/DE102020123415B4/de active Active
-
2021
- 2021-09-08 CN CN202180073189.5A patent/CN116601420A/zh active Pending
- 2021-09-08 EP EP21773742.8A patent/EP4192378A1/de active Pending
- 2021-09-08 WO PCT/EP2021/074628 patent/WO2022053471A1/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CN116601420A (zh) | 2023-08-15 |
DE102020123415B4 (de) | 2022-12-22 |
WO2022053471A9 (de) | 2023-05-19 |
DE102020123415A1 (de) | 2022-03-10 |
WO2022053471A1 (de) | 2022-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110769771B (zh) | 三维机器人生物打印机 | |
Jiang et al. | Experimental study of needle–tissue interaction forces: effect of needle geometries, insertion methods and tissue characteristics | |
US8036448B2 (en) | Methods and devices for tattoo application and removal | |
DE102006002001B4 (de) | Verfahren zur Bestimmung der räumlichen Relation eines Auges einer Person bezüglich einer Kameravorrichtung | |
Keriquel et al. | In vivo bioprinting for computer-and robotic-assisted medical intervention: preliminary study in mice | |
DE60021063T2 (de) | Vorichtung zur behandlung von gewebe | |
EP2337534B1 (de) | Vorrichtung, verfahren und steuerprogramm für ophthalmologische, insbesondere refraktive laserchirurgie | |
DE19914455B4 (de) | Verfahren zur Bestimmung der Bewegung eines Organs oder Therapiegebiets eines Patienten sowie hierfür geeignetes System | |
DE69827517T2 (de) | Führung für chirurgische instrumente | |
DE69633520T2 (de) | Enthaaren durch selektive photothermolyse mit hilfe eines alexandrite-lasers | |
DE10047382C2 (de) | Röntgenkalibrierphantom, Verfahren zur markerlosen Registrierung für navigationsgeführte Eingriffe unter Verwendung des Röntgenkalibrierphantoms und medizinisches System aufweisend ein derartiges Röntgenkalibrierphantom | |
DE60025186T2 (de) | Haartransplantationsvorrichtung | |
DE202009018659U1 (de) | System für eine kosmetische Behandlung und Bildgebung | |
EP1328208A1 (de) | Verfahren, vorrichtung und navigationshilfe zur navigation bei medizinischen eingriffen | |
DE102005014623A1 (de) | Chirurgisches System zum Präparieren eines Implantats und Verfahren zum Präparieren eines Implantats | |
CN107616838A (zh) | 一种带固定装置的3d打印个性化柱塞式穿刺治疗模板 | |
DE112010001833T5 (de) | Vcrrichtung und Verfahren zur dermatologischen Behandlung | |
CN109688964A (zh) | 用于毛发去除的自动化系统和方法 | |
DE10136709A1 (de) | Vorrichtung und Verfahren zum Durchführen von operativen Eingriffen an einem Patienten | |
WO2008085758A2 (en) | Methods and devices for tattoo application and removal | |
WO2022053471A1 (de) | Tröpfchenweise digital gesteuertes aufbringen einer kryogenen flüssigkeit | |
EP1513445B1 (de) | Pneumatisches hautelastizitätsmessgerät | |
KR20210107061A (ko) | 피부과학적 냉동 분무 디바이스들을 위한 자동화된 제어 및 위치설정 시스템들 | |
EP2621329A1 (de) | Anordnung und verfahren zur durchführung einer chirurgischen behandlung eines auges | |
DE10137914A1 (de) | Verfahren zur Ermittlung einer Koordinatentransformation für die Navigation eines Objekts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230309 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240802 |